Trends and patterns of antibiotic consumption in Shanghai municipality, China: A 6 year surveillance with sales records, 2009-14

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 6, 2016, Pages 1723-1729

  Lin, Hai ^a,b   Dyar, Oliver James ^c   Rosales Klintz, Senia ^c   Zhang, Jianzhong ^a   Tomson, Göran ^c   Hao, Mo ^a   Lundborg, Cecilia Stålsby ^c  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Health Development Research Center   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ARTICLE; CHINA; DRUG MARKETING; DRUG USE; HUMAN; OBSERVATIONAL STUDY; PRIMARY HEALTH CARE; QUALITY CONTROL; REIMBURSEMENT; RETROSPECTIVE STUDY; SECONDARY CARE CENTER; TERTIARY CARE CENTER; URBAN POPULATION; CITY; COMMERCIAL PHENOMENA; DRUG UTILIZATION; HOSPITAL; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; CHINA; CITIES; COMMERCE; DRUG UTILIZATION; HOSPITALS; HUMANS; RETROSPECTIVE STUDIES;

EID: 84973387016     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw013     Document Type: Article

References (44)

1. WHO. Antimicrobial Resistance: Global Report on Surveillance 2014. Geneva, Switzerland: WHO, 2014. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf.
2. Laxminarayan R, Duse A, Wattal C et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013; 13: 1057-98.
3. Van Boeckel TP, Gandra S, Ashok A et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014; 14: 742-50.
4. State Council of China. Opinions on Deepening the Reform of the Medical and Health Care System. 2009. http://www.china.org.cn/government/ scio-press-conferences/2009-04/09/content_17575378.htm.
5. Shi L, Yang HY, Cheng G et al. Time trends and determinants of pharmaceutical expenditure in China (1990-2009). Pharmacoeconomics 2014; 32:257-64.
6. Lu Y, Hernandez P, Dele A et al. Medicine expenditures. In: The World Medicines Situation 2011. Geneva, Switzerland: WHO, 2011. http://apps. who.int/medicinedocs/documents/s20054en/s20054en.pdf.
7. Tao D, Hawkins L, Wang H et al. Fixing the public hospital system in China. The World Bank 2010; 2: 8-20.
8. Dong L, Yan H, Wang D. Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract 2011; 28: 63-7.
9. Li Y, Xu J,Wang F et al. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff (Millwood) 2012; 31: 1075-82.
10. Yin X, Song F, Gong Yet al. A systematic review of antibiotic utilization in China. J Antimicrob Chemother 2013; 68: 2445-52.
11. Xiao YH, Giske CG, Wei ZQ et al. Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat 2011; 14: 236-50.
12. Tomson G, Vlad I. The need to look at antibiotic resistance from a health systems perspective. Ups J Med Sci 2014; 119: 117-24.
13. Xiao Y, Li L. Legislation of clinical antibiotic use in China. Lancet Infect Dis 2013; 13: 189-91.
14. SFDA of China. Notice on Strengthening Antimicrobials Sales in Pharmacy Retailers to Rationalize Drug Utilizations. 2003. http://www.sda. gov.cn/WS01/CL0055/10126.html.
15. Ministry of Health of China. National Guiding Principles for Antimicrobial Clinical Use. 2004. http://www.sda.gov.cn/WS01/CL0056/10752.html.
16. Yi H, Miller G, Zhang L et al. Intended and unintended consequences of China's zero markup drug policy. Health Aff (Millwood) 2015; 34: 1391-8.
17. Song P, LiW, Zhou Q. An outpatient antibacterial stewardship intervention during the journey to JCI accreditation. BMC Pharmacol Toxicol 2014; 15: 8.
18. Hou D, Wang Q, Jiang C et al. Evaluation of the short-term effects of antimicrobial stewardship in the intensive care unit at a tertiary hospital in China. PLoS One 2014; 9: e101447.
19. Vander SR, Elseviers MM, Ferech M et al. European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol 2004; 58: 419-28.
20. Zarb P, Amadeo B, Muller A et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother 2011; 66: 443-9.
21. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi3-12.
22. The World Bank. New Country Classifications. 2013. http://data. worldbank.org/news/new-country-classifications.
23. Shanghai Municipal Bureau of Health. Annual Report of the Health Status of Shanghai. 2013. http://www.wsjsw.gov.cn/wsj/n2006/n2021/ index.html.
24. Agency For Public Health Inspection. Assessment Report on Shanghai Health Supervision Situation, Shanghai. 2013.
25. Shanghai Municipal Bureau of Statistics. Shanghai Statistics Year Book. 2014. http://www.stats-sh.gov.cn/tjnj/nje14.htm?d1=2014tjnje/E0201. htm.
26. Wang L, Jin C, Li F et al. Analysis on the provider distribution of Shanghai total expenditure on health. Chinese Health Econ 2012; 11: 11-4.
27. WHO. Anatomical Therapeutic Chemical (ATC) Classification System:Guidelines for ATC Classification and DDD Assignment. Oslo: WHO Collaborating Centre for Drug Statisitcs Methodology, 2013.
28. Ministry of Health of China. Antibiotics Dictionary and DDDs. Network of Antibiotics Clinical Use Surveillance. 2011. http://lqws.luqiao.gov.cn/YGGC/ ArticleView.aspx?ID=32302.
29. Ferech M, Coenen S, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 2006; 58: 401-7.
30. Goossens H, Ferech M, Vander SR et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
31. ECDC. Surveillance of Antimicrobial Consumption in Europe 2012. 2014. http://ecdc.europa.eu/en/publications/Publications/antimicrobialconsumption- europe-esac-net-2012.pdf.
32. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother 2011; 66 Suppl 6: vi71-7.
33. Coenen S, Ferech M, Haaijer-Ruskamp FM et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 2007; 16: 440-5.
34. Bergman U, Popa C, Tomson Y et al. Drug utilization 90%-a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998; 54: 113-8.
35. Xiao Y, Zhang J, Zheng B et al. Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med 2013; 10: e1001556.
36. Bao L, Peng R, Wang Y et al. Significant reduction of antibiotic consumption and patients' costs after an action plan in China, 2010-2014. PLoS One 2015; 10: e118868.
37. Sun J, Shen X, Li Met al. Changes in patterns of antibiotic use in Chinese public hospitals (2005-2012) and a benchmark comparison with Sweden in 2012. J Glob Antimicrob Resist 2015; 3: 95-102.
38. Yip W, Hsiao W. Harnessing the privatisation of China's fragmented health-care delivery. Lancet 2014; 384: 805-18.
39. Jin L. Health care delivery system: China. In: The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society. Wiley Online Library, 2014; 795-802.
40. Versporten A, Coenen S, Adriaenssens N et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6:vi25-35.
41. Coenen S, Muller A, Adriaenssens N et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe. J Antimicrob Chemother 2009; 64: 200-5.
42. Shanghai Municipal Committee of Health and Family Planning. Regional Health Planning of Shanghai Municipality (2010-2020). 2012. http://www.wsjsw.gov.cn/wsj/n2373/n2374/n2378/u1ai132559.html.
43. Jin C, Wang L, Hu S et al. The study on the process and impact of external-care-seeking behavior in Shanghai. Open J Prev Med 2015; 5: 103.
44. Versporten A, Bolokhovets G, Ghazaryan L et al. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis 2014; 14: 381-7.